Prevention & lipidsResearch article
Omega-3 fatty acids for cardiovascular event lowering
- Narrative review
Study context
- Population
- Patients at high cardiovascular (CV) risk with residual risk despite low-density lipoprotein cholesterol (LDL-C) lowering, including hypertriglyceridaemia treated with statins
Main finding
As reported in the abstract
CV event lowering with omega-3 fatty acids
- Omega-3 fatty acids have shown mixed results in CV outcomes trials
- Icosapent ethyl (purified eicosapentaenoic acid (EPA)) has compelling evidence in lowering residual CV risk in patients with hypertriglyceridaemia treated with statins
Original publication
Omega-3 fatty acids for cardiovascular event lowering. Eur J Prev Cardiol. Published 3 January 2024. doi:10.1093/eurjpc/zwae003
Summarised from the published abstract; every number is checked against it